Plasma Aβ 42 as a biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: Evidence from the PharmaCog/E-ADNI Study

Diego Albani, Moira Marizzoni, Clarissa Ferrari, Federica Fusco, Lucia Boeri, Ilaria Raimondi, Jorge Jovicich, Claudio Babiloni, Andrea Soricelli, Roberta Lizio, Samantha Galluzzi, Libera Cavaliere, Mira Didic, Peter Schönknecht, José Luis Molinuevo, Flavio Nobili, Lucilla Parnetti, Pierre Payoux, Luisella Bocchio, Marco SalvatorePaolo Maria Rossini, Magda Tsolaki, Pieter Jelle Visser, Jill C. Richardson, Jens Wiltfang, Régis Bordet, Olivier Blin, Gianluigi Forloni, Giovanni B. Frisoni

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Plasma Aβ <sub>42</sub> as a biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: Evidence from the PharmaCog/E-ADNI Study'. Together they form a unique fingerprint.

Medicine & Life Sciences